Consistent with the findings in ESRRA null mice, ESRRA inverse agonists, compound 29 (C29) and compound 50 (C50), also show obesity resistance in DIO mouse models [94,95,96]. Here, ESRRA is linked to obesity due to melanocortin 4 receptor deficiency.